Application of plant derived compounds to control fungal spoilage and mycotoxin production in foods
L da Cruz Cabral, VF Pinto, A Patriarca - International journal of food …, 2013 - Elsevier
Food decay by spoilage fungi causes considerable economic losses and constitutes a
health risk for consumers due to the potential for fungi to produce mycotoxins. The …
health risk for consumers due to the potential for fungi to produce mycotoxins. The …
Alternaria in Food: Ecophysiology, Mycotoxin Production and Toxicology
HB Lee, A Patriarca, N Magan - Mycobiology, 2015 - Taylor & Francis
Alternaria species are common saprophytes or pathogens of a wide range of plants pre-and
post-harvest. This review considers the relative importance of Alternaria species, their …
post-harvest. This review considers the relative importance of Alternaria species, their …
Prevalence of mycotoxins in foods and decontamination
A Patriarca, VF Pinto - Current Opinion in Food Science, 2017 - Elsevier
Highlights•Mycotoxins are toxic secondary metabolites produced by filamentous
fungi.•Aspergillus, Penicillium, Alternaria and Fusarium are the main toxigenic …
fungi.•Aspergillus, Penicillium, Alternaria and Fusarium are the main toxigenic …
Clinical portrait of the SARS-CoV-2 epidemic in European patients with cancer
The SARS-CoV-2 pandemic significantly affected oncology practice across the globe. There
is uncertainty as to the contribution of patients' demographics and oncologic features to …
is uncertainty as to the contribution of patients' demographics and oncologic features to …
Variability of aflatoxin and cyclopiazonic acid production by Aspergillus section Flavi from different substrates in Argentina
G Vaamonde, A Patriarca, VF Pinto, R Comerio… - International journal of …, 2003 - Elsevier
Aspergillus section flavi strains isolated from peanuts, wheat and soybean grown in
Argentina were screened for aflatoxins (type B and G) and cyclopiazonic acid (CPA) …
Argentina were screened for aflatoxins (type B and G) and cyclopiazonic acid (CPA) …
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
A Agathangelidis, A Chatzidimitriou… - Blood, The Journal …, 2021 - ashpublications.org
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients
with (quasi) identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain …
with (quasi) identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain …
Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry
Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …
improved in terms of disease management and capacity is yet to be defined. Objective To …
Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the …
Summary Background The omicron (B. 1.1. 529) variant of SARS-CoV-2 is highly
transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due …
transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due …
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial
T Barbui, AM Vannucchi, V De Stefano… - The Lancet …, 2021 - thelancet.com
Background There is no evidence that phlebotomy alone is sufficient to steadily maintain
haematocrit on target level in low-risk patients with polycythaemia vera. This study aimed to …
haematocrit on target level in low-risk patients with polycythaemia vera. This study aimed to …
[HTML][HTML] High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
T Barbui, AM Vannucchi, A Alvarez-Larran, A Iurlo… - Leukemia, 2021 - nature.com
We report the clinical presentation and risk factors for survival in 175 patients with
myeloproliferative neoplasms (MPN) and COVID-19, diagnosed between February and …
myeloproliferative neoplasms (MPN) and COVID-19, diagnosed between February and …